Search
for
Sort by
Research 421–450 of 1000+
- 575 An extract of Leontopodium alpinum prolongs anagen phase in human hair follicles ex vivo
- Exploring the therapeutic potential of naturally occurring taxifolin, a dietary flavonoid: an updated comprehensive review
- Human Scalp Hair Follicles Are Both a Target and a Source of Prolactin, which Serves as an Autocrine and/or Paracrine Promoter of Apoptosis-Driven Hair Follicle Regression
- Nucleic acid-induced chemokine expression in keratinocytes: Implications for skin inflammation
- Application and progress of induced pluripotent stem in chronic wound healing: a narrative review
- Radiotherapy-Induced Skin Fibrosis: Pathophysiology, Emerging Therapeutics, and the Role of Dermatology
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- The Safety and Efficacy of Tofacitinib in 24 Cases of Pediatric Rheumatic Diseases: Single Centre Experience
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- Effectiveness of baricitinib in severe alopecia areata in real life: a retrospective study of 87 patients.
- Tofacitinib Loaded Squalenyl Nanoparticles for Targeted Follicular Delivery in Inflammatory Skin Diseases
- Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
- 153 Effectiveness of OR-101, a next generation highly selective JAK3 inhibitor, in a humanized murine model of alopecia areata
- Delayed granulomatous eruption of the nose associated with ruxolitinib
- Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers
- JAK1 gain-of-function variant causes alopecia areata, atopic dermatitis, and autoimmune thyroid disease
- JAK inhibitors in dermatology: The promise of a new drug class
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
- Interleukin-15 and Tumor Necrosis Factor-α in Iraqi Patients with Alopecia Areata
- Review of Promising Off-Label Use of Deucravacitinib
- Short-term Efficacy of Tofacitinib, a JAK Inhibitor, in IFIH1-related Aicardi-Goutières Syndrome
- Tru9I Variant as a Novel Genetic Marker for Vitamin D Deficiency in Alopecia Areata
- LB1048 Effectiveness of OR-101 in a murine model of atopic dermatitis
- 0480 Upadacitinib monotherapy for treatment of pyoderma gangrenosum: A case series
- A phase 2a trial of brepocitinib for cicatricial alopecia
- Case Report: Successful Treatment of Alopecia Universalis With Tofacitinib and Increased Cytokine Levels: Normal Therapeutic Reaction or Danger Signal?
- Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis
- Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata
- Tofacitinib Treatment in Patients With Active COVID-19 Infection
- Abrocitinib Treatment in Diffuse Alopecia Areata: A Case Report and a Literature Review